PortfoliosLab logoPortfoliosLab logo
MWA vs. NBIX
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

MWA vs. NBIX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mueller Water Products, Inc. (MWA) and Neurocrine Biosciences, Inc. (NBIX). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MWA vs. NBIX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
MWA
Mueller Water Products, Inc.
15.68%7.01%58.45%36.27%-23.81%18.06%5.45%34.32%-26.09%-4.59%
NBIX
Neurocrine Biosciences, Inc.
-7.11%3.90%3.60%10.31%40.24%-11.14%-10.83%50.53%-7.96%100.49%

Fundamentals

Market Cap

MWA:

$4.32B

NBIX:

$13.50B

EPS

MWA:

$1.27

NBIX:

$4.69

PE Ratio

MWA:

21.67

NBIX:

28.08

PEG Ratio

MWA:

0.70

NBIX:

0.55

PS Ratio

MWA:

3.00

NBIX:

4.70

PB Ratio

MWA:

4.25

NBIX:

4.15

Total Revenue (TTM)

MWA:

$1.44B

NBIX:

$2.86B

Gross Profit (TTM)

MWA:

$537.60M

NBIX:

$2.81B

EBITDA (TTM)

MWA:

$311.60M

NBIX:

$719.10M

Returns By Period

In the year-to-date period, MWA achieves a 15.68% return, which is significantly higher than NBIX's -7.11% return. Both investments have delivered pretty close results over the past 10 years, with MWA having a 12.28% annualized return and NBIX not far behind at 12.23%.


MWA

1D
2.38%
1M
-8.15%
YTD
15.68%
6M
8.29%
1Y
9.30%
3Y*
27.12%
5Y*
15.92%
10Y*
12.28%

NBIX

1D
2.35%
1M
-0.39%
YTD
-7.11%
6M
-6.15%
1Y
19.11%
3Y*
9.18%
5Y*
6.06%
10Y*
12.23%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MWA vs. NBIX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MWA
MWA Risk / Return Rank: 5151
Overall Rank
MWA Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
MWA Sortino Ratio Rank: 4646
Sortino Ratio Rank
MWA Omega Ratio Rank: 4646
Omega Ratio Rank
MWA Calmar Ratio Rank: 5555
Calmar Ratio Rank
MWA Martin Ratio Rank: 5454
Martin Ratio Rank

NBIX
NBIX Risk / Return Rank: 5959
Overall Rank
NBIX Sharpe Ratio Rank: 6262
Sharpe Ratio Rank
NBIX Sortino Ratio Rank: 5656
Sortino Ratio Rank
NBIX Omega Ratio Rank: 5757
Omega Ratio Rank
NBIX Calmar Ratio Rank: 6060
Calmar Ratio Rank
NBIX Martin Ratio Rank: 6060
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MWA vs. NBIX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mueller Water Products, Inc. (MWA) and Neurocrine Biosciences, Inc. (NBIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MWANBIXDifference

Sharpe ratio

Return per unit of total volatility

0.31

0.57

-0.26

Sortino ratio

Return per unit of downside risk

0.63

0.96

-0.33

Omega ratio

Gain probability vs. loss probability

1.08

1.14

-0.05

Calmar ratio

Return relative to maximum drawdown

0.55

0.79

-0.23

Martin ratio

Return relative to average drawdown

1.11

1.89

-0.78

MWA vs. NBIX - Sharpe Ratio Comparison

The current MWA Sharpe Ratio is 0.31, which is lower than the NBIX Sharpe Ratio of 0.57. The chart below compares the historical Sharpe Ratios of MWA and NBIX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MWANBIXDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.31

0.57

-0.26

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.53

0.19

+0.34

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.38

0.31

+0.07

Sharpe Ratio (All Time)

Calculated using the full available price history

0.08

0.13

-0.05

Correlation

The correlation between MWA and NBIX is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

MWA vs. NBIX - Dividend Comparison

MWA's dividend yield for the trailing twelve months is around 1.00%, while NBIX has not paid dividends to shareholders.


TTM20252024202320222021202020192018201720162015
MWA
Mueller Water Products, Inc.
1.00%1.14%1.15%1.72%2.18%1.55%1.72%1.71%2.20%1.28%0.83%0.91%
NBIX
Neurocrine Biosciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

MWA vs. NBIX - Drawdown Comparison

The maximum MWA drawdown since its inception was -91.80%, smaller than the maximum NBIX drawdown of -97.21%. Use the drawdown chart below to compare losses from any high point for MWA and NBIX.


Loading graphics...

Drawdown Indicators


MWANBIXDifference

Max Drawdown

Largest peak-to-trough decline

-91.80%

-97.21%

+5.41%

Max Drawdown (1Y)

Largest decline over 1 year

-16.11%

-20.90%

+4.79%

Max Drawdown (5Y)

Largest decline over 5 years

-41.27%

-42.89%

+1.62%

Max Drawdown (10Y)

Largest decline over 10 years

-46.67%

-46.39%

-0.28%

Current Drawdown

Current decline from peak

-8.82%

-15.35%

+6.53%

Average Drawdown

Average peak-to-trough decline

-40.65%

-44.05%

+3.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.05%

8.69%

-0.64%

Volatility

MWA vs. NBIX - Volatility Comparison

Mueller Water Products, Inc. (MWA) and Neurocrine Biosciences, Inc. (NBIX) have volatilities of 6.88% and 7.01%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MWANBIXDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.88%

7.01%

-0.13%

Volatility (6M)

Calculated over the trailing 6-month period

15.91%

23.02%

-7.11%

Volatility (1Y)

Calculated over the trailing 1-year period

30.19%

33.97%

-3.78%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

30.39%

32.22%

-1.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.16%

39.44%

-7.28%

Financials

MWA vs. NBIX - Financials Comparison

This section allows you to compare key financial metrics between Mueller Water Products, Inc. and Neurocrine Biosciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


200.00M300.00M400.00M500.00M600.00M700.00M800.00MAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
318.20M
805.50M
(MWA) Total Revenue
(NBIX) Total Revenue
Values in USD except per share items

MWA vs. NBIX - Profitability Comparison

The chart below illustrates the profitability comparison between Mueller Water Products, Inc. and Neurocrine Biosciences, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
37.7%
97.8%
Portfolio components
MWA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Mueller Water Products, Inc. reported a gross profit of 119.80M and revenue of 318.20M. Therefore, the gross margin over that period was 37.7%.

NBIX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Neurocrine Biosciences, Inc. reported a gross profit of 787.90M and revenue of 805.50M. Therefore, the gross margin over that period was 97.8%.

MWA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Mueller Water Products, Inc. reported an operating income of 56.70M and revenue of 318.20M, resulting in an operating margin of 17.8%.

NBIX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Neurocrine Biosciences, Inc. reported an operating income of 210.90M and revenue of 805.50M, resulting in an operating margin of 26.2%.

MWA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Mueller Water Products, Inc. reported a net income of 43.20M and revenue of 318.20M, resulting in a net margin of 13.6%.

NBIX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Neurocrine Biosciences, Inc. reported a net income of 153.70M and revenue of 805.50M, resulting in a net margin of 19.1%.